Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Telehealth & Oncology During the Fight Against COVID-19 and Its Aftermath
AVBCC
Videos
— July 16, 2020
Featuring:
Bellinda Conte
Senior Vice President
Strategy and Clinical Programs
CTCA Medicine & Science
Ann Ford
Partner/Managing Director
Femida Gwandry-Sridhar, PhD
Founder & CEO
Pulse Infoframe
Nancy Kaszak
Director
Illinois Telehealth Initiative
Partnership for a Connected Illinois
Lisa Mazur
Partner
McDermott, Will & Emery
Kenneth Miller, MD
Assoc Chief Hematology & Oncology
Tufts Medical Center
Christina Naso
Virtual Care Director
Moffitt Cancer Center
Vernessa Pollard
Partner
McDermott Will & Emery LLP
Chevon Rariy, MD
Vice President & Chair, Virtual Health, Cancer Treatment Centers of America
Chicago, IL
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief,
VBCC
;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
This webinar highlights the ways telehealth can provide the vital and essential care demanded within the field of oncology, with a focus on rural health, palliative care, digital therapeutics, clinical trials, home chemotherapy infusion, and more.
Related Articles
Addressing Challenges to Adoption of Value-Based Agreements
By
Phoebe Starr
AVBCC 2023 Summit
,
AVBCC
December 2023, Vol 14, No 6
Read Article
Bringing Stakeholders Together Bringing Stakeholders Together
AVBCC
Videos
Read Article
Why AVBCC?
AVBCC
Videos
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma